Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a major advance in cancer immunotherapy, demonstrating substantial clinical benefits in hematologic malignancies and expanding into solid tumors and autoimmune diseases. This collection highlights technological innovations, clinical applications, efficacy evaluation, safety management, and emerging indications. It brings together original research, clinical guidelines, expert consensus, and practical experience to support evidence-based clinical practice and further innovation.